High sensitivity C-reactive protein and fibrinogen in patients with coronary heart disease combined with obstructive sleep apnea hypopnea syndrome
-
摘要: 目的:探讨阻塞性睡眠呼吸暂停低通气综合征 (obstructive sleep apnea hypopnea syndrome, OSAHS) 及其干预治疗在冠心病 (coronary heart disease, CHD) 发生、发展过程中的临床意义。方法:观察测定39例CHD合并中-重度OSAHS患者、14例CHD合并轻度OSAHS患者和30例单纯CHD患者2个月规律持续气道正压通气 (continuous positive airway pressure, CPAP) 治疗前后血浆超敏C-反应蛋白 (high sensitivity C-reactive protein, hs-CRP)、纤维蛋白原 (fibrinogen, Fbg) 的水平。结果:中-重度OSAHS合并CHD组患者血浆hs-CRP、Fbg水平较其余两组明显升高, 治疗后两项检测指标均有显著下降, 轻度OSAHS合并CHD患者仅治疗前血浆hs-CRP水平较单纯CHD对照组有明显增高。结论:冠心病患者血中hs-CRP和Fbg水平随OSAHS病情加重而增高, 有效的CPAP治疗可减轻冠心病合并OSAHS患者的炎症反应和高凝状态。
-
关键词:
- 冠心病 /
- 阻塞性睡眠呼吸暂停低通气综合征 /
- 超敏C-反应蛋白 /
- 纤维蛋白原 /
- 持续气道正压通气
Abstract: Objective: To investigate the clinical significance of obstructive sleep apnea hypopnea syndrome (OSAHS) and its intervention in the occurrence and development process of coronary heart disease (CHD).Method: Determine the plasma levels of high sensitivity C-reactive protein (hs-CRP) and fibrinogen (Fbg) before and after two months of regularly continuous positive airway pressure (CPAP) treatment in 39 CHD patients combined with moderate or severe OSAHS, 14 CHD patients combined with mild OSAHS and 30 CHD patients without OSAHS.Result: In patients with CHD combined with moderate or severe OSAHS, there was remarkable increases of plasma hs-CRP and Fbg levels, and decreases with statistically significance after intervention.In patients with CHD combined with mild OSAHS, there was a statistically significant increase of plasma hs-CRP levels than in patients without OSAHS before CPAP treatment.Conclusion: In CHD patients, the plasma levels of hs-CRP and Fbg increase with OSAHS deteriorating.Effective CPAP treatment can reduce the risk factors in patients with CHD combined with OSAHS. -
-
[1] 中华医学会呼吸病学分会睡眠呼吸障碍学组.阻塞性睡眠呼吸暂停低通气综合征诊治指南 (2011年修订版)[J].中华结核和呼吸杂志, 2012, 35 (1):9-12.
[2] 上海市医学会呼吸病学分会睡眠呼吸疾病学组.上海市30岁以上人群阻塞性睡眠呼吸暂停低通气综合征流行病学调查[J].中华结核和呼吸杂志, 2003, 26 (5):268-272.
[3] MARIN J M, CARRIZO S J, VICENTE E, et al.Long-term cardiovascular outcomes in men with obstructive sleep apnoca-hypopnoea with or without treatment with continuous positive airway pressure:an observational study[J].Lancet, 2005, 365:1046-1053.
[4] 张哗, 傅春江, 方御强, 等.中重度睡眠呼吸暂停综合征患者冠状动脉造影特点分析[J].重庆医学, 2010, 39 (2):171-172.
[5] 媱丽梅.阻塞性睡眠呼吸暂停对冠状动脉支架置入后再狭窄的影响[J].中国组织工程研究与临床康复, 2012, 14 (9):1700-1702.
[6] YOKOE T, MINOGUCHI K, MATSUO H, et al.Elevated levels of C-reactive protein and interleukin-6in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure[J].Circulation, 2003, 107:1129-1134.
[7] 胡克, 姜燕, 范惠君, 等.持续气道正压通气对合并OSAHS的冠心病患者血清炎症因子水平的影响[J].中国呼吸与危重监护杂志, 2009, 8 (4):376-379.
[8] 张希龙, 殷凯生, 苏梅, 等.正压通气治疗对阻塞性睡眠呼吸暂停低通气综合征患者血栓形成机制的影响[J].中华结核和呼吸杂志, 2002, 26 (5):307-308.
[9] 张敏, 白春学, 王言森, 等.冠心病合并阻塞性睡眠呼吸暂停低通气综合征患者纤维蛋白原Bβ448基因多态性分析[J].中国临床医学, 2003, 10 (2):171-174.
[10] BUCHNER N J, SANNER B M, BORJEL J, et al.Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk[J].Am J Respir Crit Care Med, 2007, 176:1274-1280.
[11] 田卢峰, 张醒, 魏巍, 等.经鼻持续正压通气治疗夜间心绞痛合并阻塞性睡眠呼吸暂停低通气综合征[J].国际呼吸杂志, 2007, 27 (5):327-329.
[12] PEKER Y, KRAICZI H, HEDNER J, et al.An independent association between obstructive sleep apnea and coronary artery disease[J].Eur Respir J, 1999, 13:179-184.
[13] SOMERS V K, WHITE D P, AMIN R, et al.Sleep apnea and cardiovascular disease:an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association CounciI for High BIood Pressure Research ProfessionaI Education Committee.Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing[J].J Am Coll Cardiol, 2008, 52:686-717.
[14] 杨胜利, 何秉承.C反应蛋白与冠心病[J].中华心血管病杂志, 2001, 29 (3):187-188.
[15] 吴文法, 凌莉, 张素平.纤维蛋白原与心脑血管疾病关系的研究进展[J].中华老年心脑血管病杂志, 2011, 13 (12):1145-1146.
-
计量
- 文章访问数: 46
- PDF下载数: 29
- 施引文献: 0
下载: